Deans' stroke musings

Changing stroke rehab and research worldwide now.Time is Brain!Just think of all the trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 493 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It's quite disgusting that this information is not available from every stroke association and doctors group.
My back ground story is here:

Wednesday, December 14, 2011

Handheld brain bleed detector gets FDA approval

Make sure your stroke center gets this so the clot based strokes can get tPA faster.

Medical device company InfraScan has received a green light from the U.S. Food and Drug Administration to market its handheld device to detect bleeding in the brain.
The FDA granted approval for the infrascanner to be marketed through a de novo classification process, a regulatory pathway for some low- to moderate-risk medical devices that are not comparable to a legally marketed device, according to a press statement.
The infrascanner spots the presence and location of brain bleeds up to two minutes based on differential near-infrared light absorption of a hematoma and normal brain tissue. Its portable brain diagnostic device called ’MindReader’ acquires EEG data wirelessly and can be used on an Android phone.

Baruch Ben Dor, CEO of the Doylestown, Pennsylvania company, initially received a grant from the National Institutes of Health’s Small Business Innovation Research program that provides funding to commercially viable companies. It signed a $2 million contract with the U.S. Marine Corp. and U.S. Navy in 2010. Four of its systems are currently being used in the Helmand Province of Afghanistan.
Frustrated with the pace of the FDA approval process, Ben Dor enlisted the help of U.S. senators for Pennsylvania Robert P. Casey and Pat Toomey, and U.S. Rep. Allyson Schwartz earlier this year to help expedite the process.
The company pitched to potential investors at the 2011 IMPACT Venture Summit in Philadelphia last month to raise money to market the device in Europe where the infrascanner has been available.
The Centers for Disease Control and Prevention reports that 1.7 million people suffer traumatic brain injury each year.

No comments:

Post a Comment